Review



magnetic rack  (New England Biolabs)


Bioz Verified Symbol New England Biolabs is a verified supplier
Bioz Manufacturer Symbol New England Biolabs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    New England Biolabs magnetic rack
    Magnetic Rack, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 69 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/magnetic rack/product/New England Biolabs
    Average 93 stars, based on 69 article reviews
    magnetic rack - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    93
    New England Biolabs magnetic rack
    Magnetic Rack, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/magnetic rack/product/New England Biolabs
    Average 93 stars, based on 1 article reviews
    magnetic rack - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    94
    Thermo Fisher magnetic rack
    Magnetic Rack, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/magnetic rack/product/Thermo Fisher
    Average 94 stars, based on 1 article reviews
    magnetic rack - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    New England Biolabs nebnext magnetic separation rack
    Nebnext Magnetic Separation Rack, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nebnext magnetic separation rack/product/New England Biolabs
    Average 93 stars, based on 1 article reviews
    nebnext magnetic separation rack - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    95
    New England Biolabs magnetic separation
    a , PCA based on the abundance of proteins coimmunoprecipitated with each RPL3L variant. n = 3. PC1 and PC2 represent the first and second principal components. b , Enrichment of GRWD1 and C7orf50 in proteins coimmunoprecipitated with the hotspot variants D308N and G27D compared to other variants. Peptide intensities were normalized by the median of all samples and then log 2 -transformed. The error bars represent the s.d. centered around mean values. n = 3 biological replicates of immunoprecipitated lysates. c , Immunoblotting from cells transfected with the indicated amount of wild-type RPL3L or D308N plasmids in AC16 cells for 24 h. Soluble and insoluble proteins were <t>separated</t> and probed for the indicated antibodies. n = 3 independently performed biological replicates for RPL3L, RPL3 and GAPDH; n = 1 for RPL4 and C7orf50. d , Transient transfection of wild-type RPL3L and the D308N variant at the indicated ratios (total 1.5 µg plasmid) followed by the detection of RPL3L aggregates. Top, representative immunoblots. Bottom, quantification of RPL3L aggregates normalized to transfection with 100% wild-type protein. The expected values assumed no interference between wild-type and D308N protein and were calculated by subtracting the signal intensity of RPL3L bands in wild-type at 100% from D308N, split into 25% segments. n = 3 biological replicates for RPL3L–HA. Data are expressed as the mean ± s.d. e , AC16 cells with 10 ng ml −1 (+) or 100 ng ml −1 (+++) DOX for 96 h were transfected with 1 µg D308N–HA for 24 h. Aggregation of the nucleolar proteins RPL4 and C7orf50 was analyzed by immunoblotting (representative of three replicates). f , Quantification of e . n = 3 biological replicates. Data are expressed as the mean ± s.d. Multiple two-sided t -tests were used to compare low RPL3L and high RPL3L, adjusted for multiple comparisons. RPL4 P = 0.001; C7orf50 P = 0.008. * P < 0.05, ** P < 0.001.
    Magnetic Separation, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/magnetic separation/product/New England Biolabs
    Average 95 stars, based on 1 article reviews
    magnetic separation - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    93
    New England Biolabs tube magnetic separation
    a , PCA based on the abundance of proteins coimmunoprecipitated with each RPL3L variant. n = 3. PC1 and PC2 represent the first and second principal components. b , Enrichment of GRWD1 and C7orf50 in proteins coimmunoprecipitated with the hotspot variants D308N and G27D compared to other variants. Peptide intensities were normalized by the median of all samples and then log 2 -transformed. The error bars represent the s.d. centered around mean values. n = 3 biological replicates of immunoprecipitated lysates. c , Immunoblotting from cells transfected with the indicated amount of wild-type RPL3L or D308N plasmids in AC16 cells for 24 h. Soluble and insoluble proteins were <t>separated</t> and probed for the indicated antibodies. n = 3 independently performed biological replicates for RPL3L, RPL3 and GAPDH; n = 1 for RPL4 and C7orf50. d , Transient transfection of wild-type RPL3L and the D308N variant at the indicated ratios (total 1.5 µg plasmid) followed by the detection of RPL3L aggregates. Top, representative immunoblots. Bottom, quantification of RPL3L aggregates normalized to transfection with 100% wild-type protein. The expected values assumed no interference between wild-type and D308N protein and were calculated by subtracting the signal intensity of RPL3L bands in wild-type at 100% from D308N, split into 25% segments. n = 3 biological replicates for RPL3L–HA. Data are expressed as the mean ± s.d. e , AC16 cells with 10 ng ml −1 (+) or 100 ng ml −1 (+++) DOX for 96 h were transfected with 1 µg D308N–HA for 24 h. Aggregation of the nucleolar proteins RPL4 and C7orf50 was analyzed by immunoblotting (representative of three replicates). f , Quantification of e . n = 3 biological replicates. Data are expressed as the mean ± s.d. Multiple two-sided t -tests were used to compare low RPL3L and high RPL3L, adjusted for multiple comparisons. RPL4 P = 0.001; C7orf50 P = 0.008. * P < 0.05, ** P < 0.001.
    Tube Magnetic Separation, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tube magnetic separation/product/New England Biolabs
    Average 93 stars, based on 1 article reviews
    tube magnetic separation - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    94
    Vazyme Biotech Co magnetic separation rack
    a , PCA based on the abundance of proteins coimmunoprecipitated with each RPL3L variant. n = 3. PC1 and PC2 represent the first and second principal components. b , Enrichment of GRWD1 and C7orf50 in proteins coimmunoprecipitated with the hotspot variants D308N and G27D compared to other variants. Peptide intensities were normalized by the median of all samples and then log 2 -transformed. The error bars represent the s.d. centered around mean values. n = 3 biological replicates of immunoprecipitated lysates. c , Immunoblotting from cells transfected with the indicated amount of wild-type RPL3L or D308N plasmids in AC16 cells for 24 h. Soluble and insoluble proteins were <t>separated</t> and probed for the indicated antibodies. n = 3 independently performed biological replicates for RPL3L, RPL3 and GAPDH; n = 1 for RPL4 and C7orf50. d , Transient transfection of wild-type RPL3L and the D308N variant at the indicated ratios (total 1.5 µg plasmid) followed by the detection of RPL3L aggregates. Top, representative immunoblots. Bottom, quantification of RPL3L aggregates normalized to transfection with 100% wild-type protein. The expected values assumed no interference between wild-type and D308N protein and were calculated by subtracting the signal intensity of RPL3L bands in wild-type at 100% from D308N, split into 25% segments. n = 3 biological replicates for RPL3L–HA. Data are expressed as the mean ± s.d. e , AC16 cells with 10 ng ml −1 (+) or 100 ng ml −1 (+++) DOX for 96 h were transfected with 1 µg D308N–HA for 24 h. Aggregation of the nucleolar proteins RPL4 and C7orf50 was analyzed by immunoblotting (representative of three replicates). f , Quantification of e . n = 3 biological replicates. Data are expressed as the mean ± s.d. Multiple two-sided t -tests were used to compare low RPL3L and high RPL3L, adjusted for multiple comparisons. RPL4 P = 0.001; C7orf50 P = 0.008. * P < 0.05, ** P < 0.001.
    Magnetic Separation Rack, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/magnetic separation rack/product/Vazyme Biotech Co
    Average 94 stars, based on 1 article reviews
    magnetic separation rack - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    a , PCA based on the abundance of proteins coimmunoprecipitated with each RPL3L variant. n = 3. PC1 and PC2 represent the first and second principal components. b , Enrichment of GRWD1 and C7orf50 in proteins coimmunoprecipitated with the hotspot variants D308N and G27D compared to other variants. Peptide intensities were normalized by the median of all samples and then log 2 -transformed. The error bars represent the s.d. centered around mean values. n = 3 biological replicates of immunoprecipitated lysates. c , Immunoblotting from cells transfected with the indicated amount of wild-type RPL3L or D308N plasmids in AC16 cells for 24 h. Soluble and insoluble proteins were separated and probed for the indicated antibodies. n = 3 independently performed biological replicates for RPL3L, RPL3 and GAPDH; n = 1 for RPL4 and C7orf50. d , Transient transfection of wild-type RPL3L and the D308N variant at the indicated ratios (total 1.5 µg plasmid) followed by the detection of RPL3L aggregates. Top, representative immunoblots. Bottom, quantification of RPL3L aggregates normalized to transfection with 100% wild-type protein. The expected values assumed no interference between wild-type and D308N protein and were calculated by subtracting the signal intensity of RPL3L bands in wild-type at 100% from D308N, split into 25% segments. n = 3 biological replicates for RPL3L–HA. Data are expressed as the mean ± s.d. e , AC16 cells with 10 ng ml −1 (+) or 100 ng ml −1 (+++) DOX for 96 h were transfected with 1 µg D308N–HA for 24 h. Aggregation of the nucleolar proteins RPL4 and C7orf50 was analyzed by immunoblotting (representative of three replicates). f , Quantification of e . n = 3 biological replicates. Data are expressed as the mean ± s.d. Multiple two-sided t -tests were used to compare low RPL3L and high RPL3L, adjusted for multiple comparisons. RPL4 P = 0.001; C7orf50 P = 0.008. * P < 0.05, ** P < 0.001.

    Journal: Nature Cardiovascular Research

    Article Title: Pathogenetic mechanisms of muscle-specific ribosomes in dilated cardiomyopathy

    doi: 10.1038/s44161-025-00761-8

    Figure Lengend Snippet: a , PCA based on the abundance of proteins coimmunoprecipitated with each RPL3L variant. n = 3. PC1 and PC2 represent the first and second principal components. b , Enrichment of GRWD1 and C7orf50 in proteins coimmunoprecipitated with the hotspot variants D308N and G27D compared to other variants. Peptide intensities were normalized by the median of all samples and then log 2 -transformed. The error bars represent the s.d. centered around mean values. n = 3 biological replicates of immunoprecipitated lysates. c , Immunoblotting from cells transfected with the indicated amount of wild-type RPL3L or D308N plasmids in AC16 cells for 24 h. Soluble and insoluble proteins were separated and probed for the indicated antibodies. n = 3 independently performed biological replicates for RPL3L, RPL3 and GAPDH; n = 1 for RPL4 and C7orf50. d , Transient transfection of wild-type RPL3L and the D308N variant at the indicated ratios (total 1.5 µg plasmid) followed by the detection of RPL3L aggregates. Top, representative immunoblots. Bottom, quantification of RPL3L aggregates normalized to transfection with 100% wild-type protein. The expected values assumed no interference between wild-type and D308N protein and were calculated by subtracting the signal intensity of RPL3L bands in wild-type at 100% from D308N, split into 25% segments. n = 3 biological replicates for RPL3L–HA. Data are expressed as the mean ± s.d. e , AC16 cells with 10 ng ml −1 (+) or 100 ng ml −1 (+++) DOX for 96 h were transfected with 1 µg D308N–HA for 24 h. Aggregation of the nucleolar proteins RPL4 and C7orf50 was analyzed by immunoblotting (representative of three replicates). f , Quantification of e . n = 3 biological replicates. Data are expressed as the mean ± s.d. Multiple two-sided t -tests were used to compare low RPL3L and high RPL3L, adjusted for multiple comparisons. RPL4 P = 0.001; C7orf50 P = 0.008. * P < 0.05, ** P < 0.001.

    Article Snippet: Magnetic bead–antibody complex was captured using the Magnetic Separation Rack (New England Biolabs), washed two times with cytoplasmic lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM KCl, 10% glycerol and 0.1% NP-40) then three times with lysis buffer; 2× 15-cm plates were grown at 80% confluency, cells were washed two times in ice-cold PBS and lysed in 400 μl of ice-cold lysis buffer.

    Techniques: Variant Assay, Transformation Assay, Immunoprecipitation, Western Blot, Transfection, Plasmid Preparation